DAPH-12 and EGCG combinations were more effective in curing the majority of weak and strong [PSI+] strains (Fig. combinations that directly eradicate complete strain repertoires likely hold considerable therapeutic potential. Small molecules that safely eliminate self-templating amyloids and prions as well as their cytotoxic oligomeric precursors SC 66 are needed to treat, prevent or delay many deadly afflictions that plague humankind, including Alzheimer’s disease and prion disorders1-3. Yet, disrupting the exceptionally stable protein-protein interfaces of amyloids poses daunting challenges for small molecules4,5. Nonetheless, candidates have emerged that inhibit6-9and even reverse amyloidogenesis10,11. Typically, amyloidogenic proteins fold into multiple structurally distinct amyloid forms or strains, which confer distinct phenotypes12-16. Beyond sharing the cross- amyloid conformation where the -sheet strands run orthogonal to the fiber axis, however, little is known about the underlying atomic structures of these distinct strains or how structural polymorphism enciphers distinct phenotypes or disease says. This conformational diversity severely complicates the development of small molecule therapies, particularly because small molecules are only likely to be administered after substantial accumulation of diverse amyloid conformers. A key unaddressed issue is usually whether small molecules candirectlyantagonizeentirerepertoires of structurally SC 66 distinct misfolded forms. For mammalian prions, this issue is recalcitrant due to immense difficulties in generating prion strains from solely pure proteinde novothat infect wild-type animals and cause transmissible disease12. Thus, the direct effects of small molecules on distinctinfectiousPrP conformers remains unclear17, despite advances in protein misfolding cyclic amplification18,19and promising leads from cell culture20-22. Rabbit Polyclonal to DNA Polymerase lambda Furthermore, it cannot be excluded that small molecule effects in cell culture are indirect or reflect secondary alterations in proteostasis23,24. Therefore, how small molecules directly affect the folding, formation and integrity of pure mammalian prion strains remains uncertain. We sought a defined system to study different prion strains comprised of pure protein. Hence, we employed Sup35, a translation termination factor, which forms infectious amyloids that transmit heritable reductions in translation termination fidelity and comprise the yeast prion [PSI+]25. Sup35 is one of the best-studied amyloidogenic proteins, with analytical tools that are not yet available for other amyloids11,26,27. These tools provide unique opportunities to deduce new mechanistic insights concerning how small molecules affect amyloid structure. Furthermore, distinct infectious strains are readily generated using pure Sup3515,26, allowing the effects of small molecules on their folding, formation and integrity to be dissected. We employed Sup35’s prion domain name, termed NM (Fig. 1a), which spontaneously forms infectious amyloids after a lag phase15,26(Fig. 1b). During lag phase, NM rapidly SC 66 partitions between monomeric (90% of total NM) and oligomeric (10% of total NM) species11,28-31(Fig. 1b, step 1 1). NM monomers are predominantly random coil and rapidly sample multiple transient conformations32. However, the specific intermolecular contacts required for prionogenesis ultimately occur in structurally fluid NM oligomers26,30,31. NM monomers within molten oligomers gradually rearrange (Fig. 1b, step 2 2) to form (Fig. 1b, step 3 3) amyloidogenic oligomers, which have a conformation distinct to fibers31,33. The intermolecular contacts that distinguish fibers form very rapidly after the appearance of these obligate, transient intermediates26,30,31,33(Fig. 1b, step 4 4). Fibers then seed their own rapid assembly (Fig. 1b, step 5). Fibers elongate at both ends by capturing and converting monomers to the cross- form34(Fig. 1b, step 5). Short prion recognition elements within the N-terminal domain name (N), termed Head and Tail are proposed to make homotypic intermolecular contacts. Thus, fibers consist of alternating Head-to-Head and Tail-to-Tail contacts that are separated by a central core16,26,27(Fig. 1a-c). The Head and Tail regions can nucleate assembly, although SC 66 the Head nucleates more rapidly16,26,27. == Physique 1. Model of Sup35 prion assembly and chemical structure of EGCG. == (a)Sup35 is composed of a C-terminal GTPase domain name (amino acids 254-685, black) that confers translation termination activity, a highly charged middle domain name (M, amino acids 124-253, dark grey), and a prionogenic N-terminal domain name (N, amino acids 1-123, light grey) enriched in Gln, Asn, Tyr and Gly. Within N, prion recognition elements termed the Head (red) and Tail (orange), which flank a Central Core (blue), are proposed to play important roles in prion formation26,27. (b)Mechanism of Sup35 prionogenesisin vitro. Only the Head (red), Central Core (blue), and Tail (orange) regions of N are depicted. During lag phase, an equilibrium is usually rapidly established between monomers (90% of total NM) and structurally labile, molten oligomers (10% of total NM) (step 1 1). The monomers within molten oligomers gradually rearrange (step 2 2) until they access the amyloidogenic oligomer conformation (step 3 3). This transient intermediate rapidly converts to the amyloid form at the end of lag phase (step 4 4). Amyloid fibers then assemble rapidly as.